Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor. 2011

Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
Novartis Institutes for Biomedical Research, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland.

The G protein-coupled receptor GPR4 is activated by acidic pH and recent evidence indicates that it is expressed in endothelial cells. In agreement with these reports, we observe a high correlation of GPR4 mRNA expression with endothelial marker genes, and we confirm expression and acidic pH dependent function of GPR4 in primary human vascular endothelial cells. GPR4-deficient mice were generated; these are viable and fertile and show no gross abnormalities. However, these animals show a significantly reduced angiogenic response to VEGF (vascular endothelial growth factor), but not to bFGF (basic fibroblast growth factor), in a growth factor implant model. Accordingly, in two different orthotopic models, tumor growth is strongly reduced in mice lacking GPR4. Histological analysis of tumors indicates reduced tumor cell proliferation as well as altered vessel morphology, length and density. Moreover, GPR4 deficiency results in reduced VEGFR2 (VEGF Receptor 2) levels in endothelial cells, accounting, at least in part, for the observed phenotype. Our data suggest that endothelial cells sense local tissue acidosis via GPR4 and that this signal is required to generate a full angiogenic response to VEGF.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
January 2016, PloS one,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
December 2011, Cancer letters,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
January 2007, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
February 2020, iScience,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
June 2007, Life sciences,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
October 2019, EBioMedicine,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
February 2018, Journal of Crohn's & colitis,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
September 2008, Neoplasia (New York, N.Y.),
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
December 2016, American journal of physiology. Renal physiology,
Lorenza Wyder, and Thomas Suply, and Bérangère Ricoux, and Eric Billy, and Christian Schnell, and Birgit U Baumgarten, and Sauveur Michel Maira, and Claudia Koelbing, and Mireille Ferretti, and Bernd Kinzel, and Matthias Müller, and Klaus Seuwen, and Marie-Gabrielle Ludwig
March 1998, Cancer research,
Copied contents to your clipboard!